Abstract
Novel pyrrolo[2,3-d]pyrimidine antifolates (1a, b and 2a, b) with a nitrogen atom in the bridge chain between the 2,4-diaminopyrrolo[2,3-d]pyrimidine and phenylene rings were designed and efficiently synthesized. These compounds exhibited more potent inhibitory activities than methotrexate (MTX) against the proliferation of human epidermoid carcinoma KB cells and human non-small cell lung carcinoma A549 cells despite their modest dihydrofolate reductase (DHFR)-inhibitory potency.
MeSH terms
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / pharmacology
-
Carcinoma, Non-Small-Cell Lung / pathology
-
Carcinoma, Squamous Cell / pathology
-
Cell Division / drug effects
-
Folic Acid Antagonists / chemical synthesis*
-
Folic Acid Antagonists / pharmacology
-
Humans
-
Lung Neoplasms / pathology
-
Magnetic Resonance Spectroscopy
-
Methotrexate / analogs & derivatives
-
Methotrexate / chemistry
-
Microcomputers
-
Nitrogen
-
Pyrimidines / chemistry*
-
Pyrimidines / pharmacology
-
Structure-Activity Relationship
-
Tumor Cells, Cultured
Substances
-
Antineoplastic Agents
-
Folic Acid Antagonists
-
Pyrimidines
-
TNP 351
-
Nitrogen
-
Methotrexate